- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06354192
Precision Nudging for Hypertension Management: Observational Study
November 20, 2025 updated by: Lirio
Data-driven Personalization for Inclusive Outreach and Equitable Outcomes in a Digital Health Intervention for Hypertension Management: A Prospective Observational Study
The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management.
In the current intervention, behavioral reinforcement learning is applied to personalize intervention content to maximize the behavioral outcomes of three target behaviors critical for effective hypertension management: clinical encounters, medication adherence, and self-monitoring of blood pressure (SMBP).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
12000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sarah Deedat, PhD
- Phone Number: 865-243-8000
- Email: sdeedat@lirio.com
Study Contact Backup
- Name: Amy Bucher, PhD
- Phone Number: 865-839-6158
- Email: abucher@lirio.com
Study Locations
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27401
- Recruiting
- Cone Health clinics
-
Contact:
- Sarah Deedat, PhD
- Phone Number: 865.243.8000
- Email: sdeedat@lirio.com
-
Contact:
- Amy Bucher, PhD
- Phone Number: 865.243.8000
- Email: abucher@lirio.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This observational study will follow participants enrolled in a digital health intervention for hypertension management at one of nine Cone Health Community Access Clinics.
Description
Inclusion Criteria:
- Patient of Cone Health.
- Hypertension condition considered "uncontrolled" (signaled by an eligibility indicator).
- Most recent blood pressure reading is at or higher than 160/90 (lowered to 140/90 in April 2025 in accordance with approved protocol)
Exclusion Criteria:
- Non-English speaking.
- Globally unsubscribed.
- Locally unsubscribed.
- Deceased.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Precision Nudging for Hypertension Management
All participants in this study will receive the digital health intervention.
|
The hypertension digital health intervention under study combines behavioral science theory with a type of machine learning called reinforcement learning to enable precision nudging: the selection, assembly, and delivery of behavioral science-based messages created to address barriers to, and promote, management of hypertension.
The behavioral design process used for the hypertension DHI intentionally includes research on traditionally underserved populations, such as racial and ethnic minorities and people with lower incomes or educational attainment.
By including the right ingredients to meet a diverse set of needs and by effectively personalizing the content each individual sees based on their own reactions, the intervention aims to improve health equity by matching each individual to the right behavioral approach.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical encounter behavioral outcome
Time Frame: 0-18 months
|
Adherence with recommended clinical encounters given eligibility based on blood pressure readings and medication
|
0-18 months
|
|
Blood pressure reading clinical outcome
Time Frame: 0-18 months
|
Blood pressure reading
|
0-18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement
Time Frame: 0-18 months
|
Digital engagement (opens, clicks, responses, etc.)
|
0-18 months
|
|
Medication adherence behavioral outcome
Time Frame: 0-18 months
|
Self-reported medication adherence
|
0-18 months
|
|
Self-monitoring of blood pressure behavioral outcome
Time Frame: 0-18 months
|
Self-reported self-monitoring of blood pressure
|
0-18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2024
Primary Completion (Estimated)
April 1, 2026
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
April 3, 2024
First Submitted That Met QC Criteria
April 3, 2024
First Posted (Actual)
April 9, 2024
Study Record Updates
Last Update Posted (Actual)
November 25, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0450
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD will not be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Precision Nudging for Hypertension Management
-
Yuju WuRecruitingHypertension | Hypertension Self-managementChina
-
LirioRochester Regional HealthCompletedHealth Behavior | Women's Health | Prevention | Annual Visit | Well VisitUnited States
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruiting
-
VA Office of Research and DevelopmentCompleted
-
Bartın UnıversityNot yet recruitingHypertension | High Blood Pressure
-
Health Services Academy, Islamabad, PakistanCompletedHypertension | Hypertensive PatientsPakistan
-
Northwestern UniversityOmron Healthcare Co., Ltd.Completed
-
Vanderbilt University Medical CenterUniversity of California, Los Angeles; Cedars-Sinai Medical CenterCompleted
-
Wake Forest University Health SciencesCompleted
-
Boston Scientific CorporationTerminatedPain | Chronic Pain | Intractable PainUnited States